This cpff to is for refurbishment and infrastructure projects focused on facility improvements within the NCI at frederick campus
Ended Awarded Last action
- Contract number
- 75N91022F00026
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,402,500
Award facts
- Opportunity
-
- NCIOSFM221044 Solicitation number
- Contract value 100% obligated
- $5,402,500.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,300 | |
| Terminate for Convenience | -$792,892 | |
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Terminate for Convenience | -$1,841,036 | |
| Other Administrative Action | $49,974 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,864,267 | |
| Change Order | $15,368 | |
| Other Administrative Action | $0 | |
| Original award | $6,109,119 |
Show all 14
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 23, 2022, with a ceiling value of $5,402,500.10 for refurbishment and infrastructure projects at the NCI Frederick campus under a cost-plus-fixed-fee structure. The order was part of the FY26 UDO Initiative and carries an ultimate completion date of September 30, 2025.
Place of performance is Frederick, MD. Leidos Biomedical Research Inc., a Federally Funded Research and Development Center (FFRDC) contractor subsidiary of Leidos Holdings, Inc., provides biomedical research and facilities support to NCI and NIH.
Service Contract Inventory reporting shows that in FY2023, the order invoiced $1.3 million with a labor footprint of 1.0 FTE and 2,068 contractor hours. The derived government-paid blended hourly rate was $608.46/hr. Subcontractor activity comprised approximately 6 percent of contractor hours in FY2023.
Quick answers
Who was awarded contract 75N91022F00026?
75N91022F00026 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 23, 2022.
How much is contract 75N91022F00026 worth?
The government has obligated $5,402,500 on 75N91022F00026.
Is contract 75N91022F00026 an order under another contract?
Yes. 75N91022F00026 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91022F00026 competed?
The extent of competition for 75N91022F00026 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award